Dr. Reddy's Srikakulam Facility Gets Form 483 After USFDA Inspection
Dr. Reddy’s Laboratories has received a Form 483 with seven observations from the United States Food and Drug Administration (USFDA) following an inspection at its formulations manufacturing facility in Srikakulam, Andhra Pradesh.
Quality / GMP | 19/07/2025 | By Dineshwori | 671
Asahi Kasei's Microza Division Earns Gold EcoVadis Rating for Sustainability Excellence
The Gold rating reflects the division’s exceptional performance, particularly in the Environment category, highlighting its continued efforts to reduce ecological impact across manufacturing, supply chains, and value-added operations at the Microza Fuji Plant.
Quality / GMP | 17/07/2025 | By Darshana | 263
LGM Pharma Expands Analytical Testing Services with New Services
These new services, now available at LGM Pharma’s Irvine, CA, facility, offer significant benefits to drug developers, including accelerated turnaround times, enhanced quality control, and cost savings.
Quality / GMP | 16/10/2024 | By Aishwarya | 775
Avery Dennison Rolls Out AD Minidose U9XM to Ensure Authenticity of Pharma Devices
The NXP U9XM chip offers a self-adjust feature to maximize product performance. It provides high read reliability and enhanced performance, even when small tagged items are densely packed in close proximity.
Quality / GMP | 28/08/2024 | By Aishwarya | 610
The 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond.
Quality / GMP | 18/10/2023 | By Manvi | 1220
Gritgen Therapeutics Launches Operations at Commercial GMP Facility in China
The facility adheres to the global cGMP standards and complies with the regulatory guidelines of authoritative agencies including the NMPA, the FDA and the EMA.
Quality / GMP | 16/10/2023 | By Manvi | 998
Aurisco's Manufacturing Site in China Clears FDA Inspection
Aurisco's Manufacturing Site in China Clears FDA Inspection
Quality / GMP | 24/08/2023 | By Sudeep Soparkar | 923
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets (OTC)
Quality / GMP | 23/08/2023 | By Sudeep Soparkar | 746
Quality / GMP | 23/08/2023 | By Sudeep Soparkar | 1437
Successful FDA inspection at Auriscos manufacturing site in Yangzhou, China
Successful FDA inspection at Aurisco's manufacturing site in Yangzhou, China
Quality / GMP | 16/08/2023 | By Sudeep Soparkar | 839
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy